Abstract—
The article provides an analysis of the dynamics of competition and dominance in the market of biologically active additives (BAA) in Russia from 2004 to 2022. The relationship between changes in the concentration of the industry and legislative acts regulating advertising and turnover of dietary supplements, as well as data on the shares of the largest manufacturers in order to identify dominant groups in the market, was analyzed. The Herfindahl–Hirschman, Linda, strength/variety (SV) matrix, and concentration ratios were used as tools. The dominant group was identified four times in the period from 2005 to 2015. It is shown that after 2010, competition in the dietary supplements market has intensified. The results of the analysis indicate similarities in the development of competition in the dietary supplements market and the drug market.
Similar content being viewed by others
Notes
DSM Group. Russian pharmaceutical market. Annual reports. 2022. https://dsm.ru/news-reports/. Accessed April 26, 2023.
Federal Law no. 38-FZ of March 13, 2006 (as amended on December 5, 2022), On Advertising, 2022. http://www.consultant.ru/document/cons_doc_LAW_58968/6147d77ef3ebff43fadce8d43d23f5e36cd7aa20. Accessed April 26, 2023.
Farmvestnik. FAS 2022 proposes to unify the registration of dietary supplements and medicines. https://pharmvestnik.ru/content/news/fas-predlagaet-unifitsirovatj-registratsiju-badov-i-lekarstv.html. Accessed April 26, 2023.
Self-regulatory organization Union of manufacturers of dietary supplements for food. http://nppbad.ru/. Accessed April 26, 2023.
Business Petersburg: RIA Panda lost 2.3 billion rubles after the ban on its dietary supplements Ali Caps. 2017. https://www.dp.ru/a/2017/02/26/Panda_ostalas_bez_doba. Accessed April 26, 2023.
More details about the calculation of SV matrix parameters can be found at http://www.svmatrix.online.
REFERENCES
A. Boyarov, A. Osmakova, and V. Popov, “Bioeconomy in Russia: Today and tomorrow,” New Biotechnol. 60, 36–43 (2021).https://doi.org/10.1016/j.nbt.2020.08.003
D. Klimanov, O. Tretyak, U. Goren, et al., “Transformation of value in innovative business models: The case of pharmaceutical market,” Forsight STI Govern. 15 (3), 52–65 (2021). https://doi.org/10.17323/2500-2597.2021.3.52.65
K. Hys, “Identification of the reasons why individual consumers purchase dietary supplements,” in Perspectives on Consumer Behaviour (Springer, Cham, 2020), pp. 193–209. https://doi.org/10.1007/978-3-030-47380-8_9
R. Lordan, “Dietary supplements and nutraceuticals market growth during the coronavirus pandemic—Implications for consumers and regulatory oversight,” Pharma Nutr. 18, 100282 (2021).https://doi.org/10.1016/j.phanu.2021
V. M. Kodentsova and D. V. Risnik, “Vitamin D—An alimentary factor in the prevention of diseases caused by its deficiency,” Med. Sovet, No. 16, 181–191 (2022). https://doi.org/10.21518/2079-701X-2022-16-6-181-191
S.-H. Jo, S. H. Han, S.-H. Kim, et al., “Cardiovascular effects of omega-3 fatty acids: Hope or hype?,” Atherosclerosis 322, 15–23 (2021). https://doi.org/10.1016/j.atherosclerosis.2021.02.014
R. Lordan, H. M. Rando, and C. S. Greene, “Dietary supplements and nutraceuticals under investigation for COVID-19 prevention and treatment,” mSystems 6 (3), e00122-21 (2021). https://doi.org/10.1128/mSystems.00122-21
M. Kamiński, M. Kręgielska-Narożna, and P. Bogdański, “Determination of the popularity of dietary supplements using Google search rankings,” Nutrients 12, 908 (2020).https://doi.org/10.3390/nu12040908
I. Levy, et al., “Adverse events associated with interactions with dietary and herbal supplements among inpatients,” Br. J. Clin. Pharmacol. 83, 836–845 (2017). https://doi.org/10.1111/bcp.13158
C. W. Binns, M. K. Lee, and A. H. Lee, “Problems and prospects: Public health regulation of dietary supplements,” Annu. Rev. Public Health 39, 403–420 (2018). https://doi.org/10.1146/annurev-publhealth-040617-013638
E. D. Gorshkova, “Features of advertising communication in the market of biologically active additives,” Gum. Nauki. Vestn. Fin. Univ. 12 (3), 26–29 (2022). https://doi.org/10.26794/2226-7867-2022-12-3-26-29
N. M. Sergeeva, “Trends in the development of the market for biologically active additives in the Russian Federation during the coronavirus pandemic,” Azimut Nauchn. Issled.: Ekon. Upr. 10 (35), 285–288 (2021). https://doi.org/10.26140/anie-2021-1002-0058
I. S. Antonova, A. D. Vesnina, and V. G. Shadrin, “Marketing research of the market of biologically active additives,” Tekhn. Tekhnol. Pishch. Proizvod. 50 (3), 503–514 (2020). https://doi.org/10.21603/2074-9414-2020-3-503-514
L. L. Kvachakhiya, “Trends in the formation of the market for biologically active additives in Russia,” Azimut Nauchn. Issled.: Ekon. Upr. 10 (34), 170–172 (2021). https://doi.org/10.26140/anie-2021-1001-0039
N. M. Sergeeva, “On structural transformations in the market of dietary supplements in the Russian Federation during the coronavirus pandemic,” Azimut Nauchn. Issled.: Ekon. Upr. 10 (35), 289–292 (2021). https://doi.org/10.26140/anie-2021-1002-0059
N. I. Markov and E. A. Yakimova, “Analysis of competition and the level of dominance in the Russian pharmaceutical market,” Farmakoekon.: Teor. Prakt. 10 (4), 22–33 (2022). https://doi.org/10.30809/phe.4.2022.4
A. Pashkevich, “Market for dietary supplements and vitamins under sanctions: prospects for the development of dietary supplements in 2022,” Delovoi Profil’, 1–21 (2022). https://delprof.ru/upload/iblock/1ee/Analitika_DELOVOY-PROFIL_Rynok-BADov.pdf.
I. V. Grishina, A. I. Bel’chuk, and L. V. Sabel’nikov, “Import of pharmaceuticals to Russia,” Ross. Vneshneekon. Vestn. 3, 69–76 (2021). https://doi.org/10.24411/2072-8042-2021-3-69-76
M. Yu. Shevkunenko, “Strategic priorities of import substitution in the Russian pharmacological market,” Vestn. Sev.-Kavk. Fed. Univ. 3 (72), 117–124 (2019). https://vestnikskfu.elpub.ru/jour/ article/view/63/0.
D. V. Manturov, “Industrial policy in the Russian pharmaceutical industry,” Ekon. Politika, No. 13, 64–77 (2018). https://doi.org/10.18288/1994-5124-2018-2-04
E. Sapir and I. Karachev, “Common pharmaceutical market of the EAEU and Eurasian integration,” Sovrem. Evr., No. 2, 121–134 (2017). https://doi.org/10.15211/soveurope22017121134
L. Lobuteva, A. Lobuteva, O. Zakharova, O. Kartashova, and N. Kocheva, “The modern Russian pharmaceutical market: Consumer attitudes towards distance retailing of medicines,” BMC Health Serv. Res. 22, 582 (2022). https://doi.org/10.1186/s12913-022-07991-7
J. Hamulka, et al., “Dietary supplements during COVID-19 outbreak. Results of Google trends analysis supported by PLifeCOVID-19 online studies,” Nutrients 13, 54 (2020). https://pubmed.ncbi.nlm.nih.gov/33375422/. https://doi.org/10.3390/nu13010054
K. B. Kostin and L. A. Shanava, “Key trends in the development of the Russian pharmaceutical market under uncertainty,” Ekon., Predprinim. Pravo 12, 1639–1658 (2022).
N. N. Tezina, “Review of legal regulation of the FSIS MPPC project,” Vrach Inf. Tekhnol., No. S1, 39–42 (2020). https://doi.org/10.37690/1811-0193-2020-S1-39-42
S. V. Shchelokova and V. A. Vertogradov, “SV matrix: A tool for strategic competitive analysis taking into account the level of dominance,” Vestn. Mosk. Univ., Ser. 6: Ekon., No. 6, 137–162 (2021).https://doi.org/10.38050/0130010520216.7
R. M. Bukvic, R. Z. Pavlovic, and A. M. Gajic, “Possibilities of application of the index concentration of Linda in small economy, example of Serbian food industries,” Ann. Oradea Univ.: Fascicle Manage. Technol. Eng. 23 (3), 159–164 (2014). https://mpra.ub.uni-muenchen.de/81707/7/ MPRA_paper_81707.pdf.
A. A. Blokhin, I. V. Lomakin-Rumyantsev, and S. A. Naumov, “Alpha business in the Russian food market,” Ekon. Strategii, No. 6, 68–77 (2019). https://doi.org/10.33917/es-6.164.2019.68-77
N. I. Markov, “Analysis of competition and level of dominance in the market of products for the treatment of diabetes mellitus in Russia,” Med. Sovet, No. 6, 242–263 (2023). https://doi.org/10.21518/ms2023-018
S. V. Shchelokova and V. A. Vertogradov, “Individual insurance products: Is there a real choice for Russians?,” Popul. Econ. 1 (7), 1–20 (2023). https://doi.org/10.3897/popecon.7.e86059
S. Spektor, “Competition in the Brazilian automotive market in 2011–2021,” Lat. Am., No. 7, 21 (2022). https://doi.org/10.31857/S0044748X0019795-3
V. A. Bartosh and I. R. Lisetskaya, “Identification and analysis of dominant groups in the automotive market of South Africa (2010–2021),” Strategii Biz. 5 (10), 117–123 (2022). https://doi.org/10.17747/2311-7184-2022-5-117-123
O. V. Kudryavtseva, P. S. Abramova, and N. I. Markov, “Analysis of competition and dominance in the passenger car market in the Republic of Korea,” Mir Nov. Ekon. 1 (17), 12–30 (2023). https://doi.org/10.26794/2220-6469-2023-17-1-12-30
V. A. Vertogradov and S. V. Shchelokova, “Strategies for premium car brands in Russia and the actions of the regulator (2009–2021),” Mir. Nov. Ekon. 16 (2), 64–75 (2022). https://doi.org/10.26794/2220-6469-2022-16-2-64-75
A. V. Govorova, “History and paradoxes of the Chinese car market: Eastern strategies and the Asian regulator,” Stud. Russ. Econ. Dev. 34, 150–158 (2023). https://doi.org/10.1134/S1075700723010069
I. P. Suslova, I. I. Korostyleva, and S. V. Spektor, “Dominanc of national systems of higher education in the international market,” Ekon. Strategii, No. 3, 148–163 (2022). https://doi.org/10.33917/es-3.183.2022.148-163
V. A. Vertogradov and S. V. Shchelokova, “Evolution of competition and Russia’s position in the world markets for mineral fertilizers,” APK: Ekon., Upr., No. 9, 91–103 (2022). https://doi.org/10.33305/229-91
E. A. Yakimova and V. E. Zabegaeva, “Producer competition on the Russian healthy drinks market in 2012–2021,” Sovrem. Konkurentsiya 17 (1), 5–31 (2023). https://doi.org/10.37791/2687-0657-2023-17-1-5-31
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The author declares that he has no conflicts of interest.
Rights and permissions
About this article
Cite this article
Markov, N.I. Analysis of Competition and Domination in the Market of Biologically Active Supplements in Russia. Stud. Russ. Econ. Dev. 34, 640–650 (2023). https://doi.org/10.1134/S107570072305009X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S107570072305009X